Doctor Explains How To Make Peptides 10x STRONGER!
A clinic owner's four-layer framework for peptide protocols (foundation, dose timing, sequencing, sourcing), mixed with promotion of his own prescribing service.
With Dr. Jones, DC (DC)
Key moments
Tap a moment to play the video from there.
- 0:00Why adding more peptides backfiresJones says stalled results are usually not fixed by a new compound or a higher dose, and previews four layers, three of which have nothing to do with which peptide is used.
- 1:09Receptors, inflammation and the speaker analogyHe compares peptides to speakers on a weak power supply and says chronic inflammation desensitizes receptors, so the same dose stops registering. He calls the fix receptor priming.
- 2:31Layer one: the Wolverine stackHe describes BPC-157 with TB-500 as the foundation, mentions KPV as a gut add-on, and says doses and duration matter more than a short run.
- 4:58Layer two: timing growth hormone peptidesJones links dosing windows to insulin and the natural sleep pulse of growth hormone, and names pre-sleep as the primary window.
- 6:37Two patients, same compoundsHe contrasts a patient dosing a large stack at random times with one who phases the same compounds in order, and says only the second saw results.
- 8:32Layer three: sequencingHe criticizes running six to ten peptides at once and says the protocol should be layered over weeks.
- 9:14Three phases of a protocolHe outlines foundation, then a metabolic phase with GLP-1s, then growth hormone peptides, and says cycling and washouts follow.
- 11:51Layer four: source and dose fidelityJones says research-site vials may not contain what the label states and suggests third-party batch testing or a 503A compounding pharmacy.
- 14:09Final thoughts and clinic offerHe asks viewers to name their weakest layer and describes his clinic's prescription and coaching services, including what it does not offer.
What the video says
Dr. Jones, DC, argues that people whose peptide results stall should stop adding compounds or raising doses. In his view the peptide is not the main variable. He says the environment underneath it is, and he organizes his advice into four layers that he claims decide whether a protocol works at 30% or 100%. He bases this on patients he says he coaches at his clinic.
The first layer is foundation. Jones says chronic inflammation appears to reduce sensitivity in some receptor systems that peptides signal through, which he uses to explain why a dose that worked in month one can seem weaker by month four. His fix is what he calls receptor priming, built on the BPC-157 and TB-500 pairing he calls the Wolverine stack, with KPV as an optional add-on for gut-focused work. He says it must be run at doses set by a prescriber and for longer than a few weeks. The second layer is timing. He says growth hormone releasing peptides such as CJC, ipamorelin, sermorelin and tesamorelin work best pre-sleep, 90 to 120 minutes after the last meal, because insulin suppresses growth hormone release. He gives fasted morning as a secondary window.
The third layer is sequencing. Jones describes two patients on the same compounds, one dosing at random times with everything at once and one phasing the protocol in over weeks, and says only the second saw clear changes. His outline is foundation for at least four weeks, then a metabolic phase that includes GLP-1s, then growth hormone peptides, with breaks and washouts. He says he would drop tesamorelin when CJC and ipamorelin are already in use.
The fourth layer is source and dose fidelity. He says research-site vials may contain less than labeled, degraded material or the wrong compound, and suggests batch testing by mass spectrometry, which he puts at $100 to $300 per sample, if someone goes that route. He recommends peptides from 503A compounding pharmacies. The video also repeatedly promotes his clinic's prescription and coaching services, and he states that the clinic does not oversee peptides obtained elsewhere.
On each compound
BPC-1572:31
Jones calls BPC-157 the core of the foundation layer. He says it has strong documented effects on inflammation and the gut lining and acts across muscle, tendon and vascular tissue.
See how your DNA reads BPC-157TB-5003:32
According to Jones, TB-500 supports the cellular machinery of repair and recovery, especially in soft tissue and the vascular system, and is paired with BPC-157 in the Wolverine stack.
See how your DNA reads TB-500KPV3:32
Jones mentions KPV as an add-on to BPC-157 for patients with deeper gut issues, used with or instead of it. He gives no further detail.
See how your DNA reads KPVCJC-12955:05
Jones groups CJC with ipamorelin as a growth hormone releasing stack and recommends dosing it pre-sleep. He places it in the final phase of his sequence.
See how your DNA reads CJC-1295Ipamorelin5:05
Jones says ipamorelin is usually stacked with CJC and signals the pituitary to release a pulse of growth hormone. He says it works best away from meals and before sleep.
See how your DNA reads IpamorelinTesamorelin7:37
Jones lists tesamorelin among growth hormone releasing compounds. He says it does the same thing as CJC with ipamorelin, so his second example patient does not need it.
See how your DNA reads TesamorelinSermorelin5:05
Jones names sermorelin as another growth hormone releasing compound and places it in the performance and recovery phase alongside CJC and ipamorelin.
See how your DNA reads Sermorelin“The peptide itself isn't the variable that's going to determine whether your protocol works.”
“You're running a chemistry experiment on yourself with an unknown variable as the input.”
What this video doesn’t settle
- The claim that chronic inflammation lowers receptor sensitivity to peptides is stated in general terms, and no study or data is cited for it.
- The patient comparison is a single anecdote from his own clinic, with no control group and no measured outcomes beyond his description.
- Doses are not given for any peptide; Jones defers to prescribers, so the video does not establish what a workable dose or duration is.
Questions this video answers
Why do peptides stop working after a few months, according to Dr. Jones?
Jones says chronic inflammation appears to reduce the sensitivity of some receptors peptides signal through, so the same dose has less effect over time. He calls his proposed fix receptor priming. He presents this as a pattern from his clinic and not as a finding from a specific study.
When does Dr. Jones say to take growth hormone peptides?
He names pre-sleep as the primary window, 90 to 120 minutes after the last meal, to line up with the natural growth hormone pulse. He gives fasted morning as a secondary window and says high insulin suppresses growth hormone release.
In what order does Dr. Jones layer peptides in a protocol?
He describes BPC-157 and TB-500 alone first, for at least four weeks. Then comes a metabolic phase that includes GLP-1s, then growth hormone peptides such as CJC, ipamorelin and sermorelin. He says the timeline is a minimum and can stretch.
What does Dr. Jones say about research-site peptides?
He says vials from overseas suppliers may hold less than labeled, degraded material or the wrong compound, with no certificate of analysis. If someone goes this route, he says each batch should go to an independent lab for mass spectrometry, which he puts at $100 to $300 per sample.
Video by Dr. Jones, DC on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
